Humana stock (NYSE: HUM) has seen about a 15% rise in a month, outperforming the broader S&P500 index, up 2%. Looking at the longer term, the S&P 500 index, with 40% gains since late 2019, has fared slightly better than Humana
HUM
This 35% rise in HUM stock since late 2019 can be attributed to 1. Humana’s revenue rising a significant 52% to $99 billion over the last twelve months, compared to $65 billion in 2019, 2. a 7% fall in its total shares outstanding to 124 million, driven by $5.8 billion spent on share repurchases over this period, partly offset by 3. a 17% fall in the company’s P/S ratio to 0.6x trailing revenues currently, compared to 0.8x in 2019. The increase in revenue and a fall in shares outstanding has meant that Humana’s revenue per share rose a stellar 63% to $797 over the last twelve months, vs. $488 in 2019. Our dashboard on Why Humana Stock Moved has more details.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.